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The interaction of a poly-functional ligand derived of o-vanillin and 2-thiophenemethylamine 
(oVATPNH2) with transition metal ions, Cu(II) and Zn(II) leads to the formation of stable coordination 
compounds, namely [Cu(oVATPNH2)2] and [Zn(oVATPNH2)2]. Their crystal structures have been 
determined by X-ray diffraction methods. Two molecules of the deprotonated ligand acting as bidentate 
build a nearly square planar environment around Cu(II) and a distorted tetrahedral coordination 
arrangement for Zn(II). The complexes were characterized by spectroscopic techniques, including solid 
state FTIR, Raman, EPR and diffuse reflectance and solution UV-vis and EPR. Their thermal behavior 
has been analyzed by means of TGA and DTA. DFT theoretical studies, using computational methods 
based on DFT, were employed to assist the interpretation and assignment of spectroscopic data. 
Cytotoxicity assays against two human breast cancer cell lines, namely MCF-7 and MDA-MB-231, 
revealed an enhancement of effectiveness of the complexes as compared with both the ligand and the 
free metal ions. The results for the copper compound are promising, as its cytotoxic effect was stronger 




Coordination chemistry of biological relevant transition metals is a subject of permanent interest in the 
search of new metallodrugs. A great number of salicylaldehyde derivatives have been extensively 
employed as active ligands because of their broad variety of applications in many fields, including the 
therapeutic activity1-3. The inclusion of heterocyclic scaffolds in the molecules has been successfully 
employed in the development of new drugs having a wide range of pharmacological effects, such as 
antimicrobial, anthelmintic, anti-inflammatory, analgesic, antipyretic, diuretic, hypoglycemic, 
anticonvulsant, anti-HIV, cytotoxic and antitumor. 4-6 In particular, poly-functional molecules containing 
thiophene are of special interest because of the participation of this heterocycle in the improvement of 
therapeutic agents.7 Additionally, the sulfur atom can act as a potential donor in the ligands depending 
on their conformational properties. 
The relevance of transition metal coordination chemistry involving this kind of ligands is based on the 
structural versatility, syntheses accessibility and wide application in different fields. They are of interest 
in food and dye industries; in analytical and agro-chemistry and they have shown catalytic, antioxidant, 
fungicidal, anti-inflammatory and antitumor activities.8-10 It is expected that complexation leads to an 
improvement in the activity of the ligand or the metal themselves. It is well known that, among the first 
row of transition metals, copper and zinc are involved in many essential biological roles and in a wide 
variety of bioinorganic systems. Furthermore, these metals have been important in the development of 
metallo-pharmaceuticals with diverse therapeutic activity in an attempt to lower the side effects. 
Examples of copper complexes involving ligands derived from heterocycles have shown relevant 
characteristics and applications.11-13 The interaction of this kind of ligands with the Zn(II) has led to 
stable complexes that have been studied in relation with the importance of this metal in biological 
functions and therapeutic activities.13-16 
Among the diversity of biological and therapeutic effects of metal complexes, antitumor activity is one 
of the most relevant.17 In particular, breast cancer is one of the more frequent causes of premature 
mortality in female population. One of the most aggressive types is the one known as triple-negative 
breast cancer. Up to the moment, chemotherapy seems to be the only possible treatment, involving 
side effects. Then, great efforts are devoted to improve therapeutic agents to optimize the treatment.18 
The selected ligand in this work (oVATPNH2, HL, see Scheme 1) has been obtained and fully 
characterized in our laboratory.19 It is the product of the reaction of o-vanillin (2-hydroxy-3-
methoxybenzaldehyde, hereafter oVa) and 2-thiophenemethylamine (TPNH2). It is an example of 






Scheme 1:oVATPNH2, HL ligand (2-methoxy-6-{(E)-[(thiophen-2-ylmethyl)imino]methyl}phenol). 
 
According to the structural properties of oVATPNH2, it could be considered as a candidate for a three 
dentate ligand with O, N, S donor atoms. Although this is not the more typical coordination feature for 
ligands containing thiophene, it has been proposed in many complexes involving different metallic 
centers.20-23 The chelating ability of this compound is examined by its interaction with Cu(II) and Zn(II) 
and the resulting complexes are presented in this work. 
The complexes have been fully characterized by means of spectroscopic (FTIR, Raman, UV-Vis and 
EPR) techniques, their thermal behavior has been explored by TGA and DTA and their crystal 
structures were determined by X-ray diffraction methods. DFT calculations were performed to 
complement experimental results and to assist in their interpretation. The cytotoxic activity of the 
complexes was essayed against two tumoral cell lines and compared with the free ligand, metal ions 
and the reference metallodrug cisplatin, with promising results in breast cancer cell lines. The 
physicochemical and structural characteristics of the compounds that are analyzed herein can help to 






The following reactants and solvents were used as provided with no further purification. Absolute 
ethanol (Soria), methanol and acetonitrile (Carlo Erba), Cu(CH3COO)2·H2O (Merck) and 
Zn(CH3COO)2·2 H2O (Mallinckrodt). 
The ligand oVATPNH2 (HL) was prepared according with previously reported data.19  
Elemental analyses were performed in an Exeter CE 440 analyser and melting points were determined 
in a Bock monoscop “M” instrument. 
The complexes were prepared according to the following procedures: 
[Cu(oVATPNH2)2] (CuL2): This complex was prepared from different copper salts, namely chloride, 
nitrate and acetate and in different solvents (ethanol, methanol, acetonitrile), but only in the following 
case it was possible to obtain a crystalline product: over a solution of Cu(CH3COO)2·H2O (0,10 mmol, 
0.0199 g) in acetonitrile (8 mL), a solution of the ligand (0,20 mmol, 0492 g) in the same solvent 
(25mL) was drop wise added under stirring and mild heating conditions. The resulting solution 
immediately changes its colour from yellow to ochre with forward precipitation of yellowish-green 
crystals. The system was kept in the same conditions for 30 minutes and the solid was isolated by 
filtration. (Yield: 65%, 0.0361 g, m.p: 237-238°C) Anal. Found: C, 55.98; H, 4.43; N, 5.12; S, 11.48% 
Calc. for C26H24N2O4S2Cu: C, 56.15; H, 4.35; N, 5.04; S, 11.53 %. 
[Zn(oVATPNH2)2] (CuL2): A solution prepared from 0,1255g of ligand (0,51mmol) in 25 mL of ethanol, 
under stirring and heating conditions, was let to achieve reflux temperature. Then, 0.0547g (0,25 mmol) 
of Zn(CH3-COO)2·2H2O (Mallinckrodt) dissolved in 5 mL of the same solvent were drop wise added. 
After four hours of reflux, a white solid was isolated by filtration and the remaining solution was kept in 
the refrigerator (4°C, approximately) during one month. A crystalline yellow solid was obtained, filtered 
off and dried in a dissector. (Yield: 32%, 0.0446 g, m.p: 203-204°C). Anal. Found: C, 55.87; H, 4.45; N, 
4.95, S, 11.54 % Calc. for C26H24N2O4S2Zn: C, 55.97; H, 4.34; N, 5.02; S, 11.49 %. 
 
2.2. X-ray diffraction data 
The measurements of complexes (I) and (II) were performed on an Oxford Xcalibur Gemini, Eos CCD 
diffractometer with graphite-monochromated MoKα (λ=0.71073 Å) radiation. X-ray diffraction intensities 
were collected (ω scans with ϑ and κ-offsets), integrated and scaled with CrysAlisPro 24 suite of 
programs. The unit cell parameters were obtained by least-squares refinement (based on the angular 
settings for all collected reflections with intensities larger than seven times the standard deviation of 
measurement errors) using CrysAlisPro. Data were corrected empirically for absorption employing the 
multi-scan method implemented in CrysAlisPro. The structures were solved by direct methods with 
SHELXS of the SHELX suit of programs 25 and the molecular models refined by full-matrix least-squares 
procedure on F2 with SHELXL of the same package. At this stage it was noted a rotational disorder of 
the five-member thiophene ring which splits into a dominant (74% for the Cu complex and 83% for the 
Zn one) conformer and a second minor one rotated from the first in 180º around the linking C-C σ-bond. 
This disorder was modeled in terms of two such rings and refined such that their occupancies summed 
up to one. The hydrogen atoms were located on stereo-chemical basis and refined with the riding model. 
The methyl groups were refined as rigid group allowed to rotate around the corresponding O-CH3 bonds 
such as to maximize the sum of the electron density at the hydrogen calculated positions. The methyl 
group of both complexes converged to staggered angular conformations.  
 
2.3. Spectroscopy 
Infrared spectra of solid samples (KBr pellets) were recorded with a Bruker Equinox 55 instrument in 
the 4000-400 cm-1 region. Raman spectra were measured with a WITEC alpha 300 RA 
spectrophotometer, using laser excitation wavelength of 532 nm and a 20x objective lens. 
Electronic spectra of the compounds and reactants were recorded in solution of dimethyl sulfoxide 
(DMSO), using 10 mm quartz cells in the spectral range from 190 to 800 nm. Diffuse reflectance 
spectra (convert in absorbance from Kubelka-Munk function) in the 250 - 800 nm range were recorded 
using BaSO4 pellet as a reference with an integrating sphere attachment. Both spectra were registered 
in a Shimadzu UV-2006 spectrophotometer. 
X-band EPR spectra were acquired on a polycrystalline samples, room temperature and frozen glassy 
solutions by using a Bruker EMX spectrometer, equipped with a Bruker ER 036TM NMR-teslameter 
and an Agilent 53150A microwave frequency counter. Variable temperature experiments were 
precisely controlled by a Bruker ER 4131VT accessory by using the combined action of a liquid 
nitrogen evaporator, a heater and the BVT3000 temperature controller. A flat quartz cell was used for 
room-temperature studies in solution, whereas the solvents mixture was quickly frozen inside the 
standard quartz tube in the experiments at 120 K. SimFonia program 26 was used to perform the 
simulated spectra and graphics were carried out with Kaleidagraph v4.1 27. Experimental details are 
given in figure captions. 
NMR samples were prepared under a nitrogen atmosphere by dissolving the suitable amount of the 
compound in 0.5 mL of pre-dried (Molecular Sieves 4Å) oxygen-free CD3)2SO and the spectra were 
recorded at 298 K. Typically, 1H NMR spectra were acquired with 32 scans into 32 k data points over a 
spectral width of 16 ppm. 1H and 13C chemical shifts were internally referenced to TMS via the residual 
1H signal of CHD2SOCD3 (δ = 2.50 ppm) and the 13C signal of (CD3)2SO (δ = 39.52 ppm), according to 
the values reported by Fulmer et al.28 Heteronuclear 2D NMR spectra such as 1H-13C HSQC, 1H-
13C HMBC were recorded using standard pulse sequences. The probe temperature (±1 K) was 
controlled by a standard unit calibrated with methanol as a reference. All NMR data processing was 
carried out using MestReNova version 10.0.2. 
 
2.4. Computational methods. 
The structures of the three complexes were optimized using the Becke's three parameters hybrid 
density functional 29 with the gradient-corrected correlation functional due to Lee, Yang, and Parr 30 as 
implemented in of the ORCA program 31. The Def2-TZVP basis set of triple-zeta quality was used for 
all the atoms.32 The experimental structures obtained from X ray diffraction were taken as starting 
geometries for Cu(oVATPNH2)2 and Zn(oVATPNH2)2. Based on spectroscopic results, a square 
pyramidal geometry was proposed in the case of VO(oVATPNH2)2. Optimizations were conducted in 
the gas phase. 
To verify whether the optimized geometries are local minima or saddle points on the potential energy 
surface of the molecules the eigenvalues of the Hessian matrix of the total energy with respect to the 
nuclear coordinates were calculated. Those eigenvalues were then transformed to harmonic vibrational 
frequencies, which were further used to aid in the assignment of the experimental vibrational 
frequencies. No factors were used to scale calculated frequencies. 
The electronic spectra of complexes were calculated using the hybrid PBE0 functional 33 as 
implemented in the ORCA program. The Def2-TZVP basis sets were used for those calculations, too. 
Solvent effects were included implicitly through the Conductor-like Screening Model (COSMO) 34 as 
implemented in the ORCA program. The results obtained by these procedures were used to assist in 
the interpretation and assignments of the spectroscopic data. 
 
2.5. Thermal analysis. 
The thermal analysis (TG and DT) of the three complexes and the ligand has been performed using 
Shimadzu TG-50 and DT-50 units, in a 25° to 800 ºC temperature range at a heating rate of 5 ºC min-1 
and oxygen flow of 80 mL min-1. 
 
2.6. Biological assays. 
2.6.1. Materials 
Tissue culture materials were purchased from Corning (Princeton, NJ, USA), Dulbecco’s modified 
Eagle’s medium (DMEM) and TrypLE ™ were purchased from Gibco (Gaithersburg, MD, USA), and 
fetal bovine serum (FBS) was purchased from Internegocios (Argentina). All the cell lines were 
purchased from ATCC (American Type Culture Collection. 
2.6.2. Cell line and growth conditions 
MCF-7 (breast) cancer cells were grown in DMEM containing 10 % FBS, 100 U/mL penicillin, and 100 
µg/mL streptomycin at 37° C in a 5 % CO2 atmosphere whilst MDA-MB-231 (triple negative breast) 
were grown in F12-DMEM. Cells were seeded in a 75-cm2 flask, and when 70–80 % of confluence was 
reached, cells were subcultured using 1 mL of TrypLE ™ per 25-cm2 flask. For experiments, cells were 
grown in multiwell plates. When cells reached the desired confluence, the monolayers were washed 
with PBS and were incubated under different conditions according to the experiments. 
2.6.3. Cell viability study: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed 
according to Mosmann 35. Briefly, cells were seeded in a 96-well dish for 24 h, and treated with 
different concentrations of compound (1-50 µM) at 37° C for 48 h. Afterward, the medium was changed 
and the cells were incubated with 0.5 mg/mL MTT under normal culture conditions for 3 h. Cell viability 
was marked by the conversion of the tetrazolium salt MTT to a colored formazan by mitochondrial 
dehydrogenases. Color development was measured spectrophotometrically with a microplate reader 
(model 7530, Cambridge Technology, USA) at 570 nm after cell lysis in DMSO (100 µL per well). Cell 
viability was plotted as the percentage of the control value. 
 
3. Results and discussion 
 
3.1. Crystal Structures 
 
Crystal data and structure refinement results are summarized in Table 1 and ORTEP 36 drawings of the 
copper and zinc complexes are shown in Figure 1. The metal ion in both complexes is coordinated to 
two, symmetry-related, Schiff bases acting as bidentate ligands through the phenoxo oxygen and the 
imine nitrogen atoms. In the copper complex, the metal ion is sited on a crystallographic inversion 
centre in a nearly square environment often found in Cu(II) coordination compounds 37-39, with d(Cu-
O)=1.887(1) Å, d(Cu-N)=1.997(2) Å and ∠(O-Cu-N)=91,25(6)º. In the zinc compound the metal is sited 
on a two-fold symmetry axis in an squashed tetrahedral environment, typical for Zn(II) and displayed 
also in complexes with related ligands  d(Zn-O)=1.921(2) Å, d(Zn-N)=1.997(2) Å and ∠(O-Zn-
N)=95.88(7)º.40-42 Complete lists of geometrical parameters are available as supplementary information 
(Tables S1-S5). 
Because of π-bond delocalization, both the arylmethylidenemethanamine and the thiophene fragments 
are planar [rms deviation of atoms from the corresponding best least-squares planes less than 0.017 
Å]. Planarity in the arylmethylidenemethanamine molecular skeleton is further stabilized by the ligand 
bite-like coordination to metal.  
The conformation and metrics of the single-charged anionic ligand can be compared with the 
corresponding geometric data reported for the uncharged pure oVATPNH2 ligand. It crystallizes in the 
monoclinic space group P21/n with two un-equivalent but structurally closely related molecules per 
asymmetric unit (Z=8), one of them showing rotational disorder of the five-member ring. The disorder 
has been modeled in term of two rings rotated from each other in 180º around the linking C-C σ-
bond.19  
Referring to the better refined, disorder-free molecule in the neutral ligand, some bond structure 
changes are expected upon deprotonation of OH group followed by formation of the metal-O and 
metal-N bonds. Main change occurs at the C-O bonds as C-OH formally single bond length of 1.351(4) 
Å shortens to 1.297(2) Å (twelve times the standard deviation σ) in the copper complex and to 1.307(2) 











Figure 1: View of [Cu(oVATPNH2)2] (CuL2) (left) and [Zn(oVATPNH2)2] (ZnL2) (right) showing the 
labeling of the non-H atoms and their displacement ellipsoids at the 30% probability level. The 
unlabeled atoms are obtained from the labeled ones through a crystallographic inversion center at the 
copper location and by a 180º rotation around a two-fold axis passing through the zinc ion, 
respectively. Metal-ligand bonds are indicated by dashed lines. For clarity, in both complexes only it is 
shown the dominant conformer of the rotationally disordered thiophene group. 
 
Table 1. Crystal data and structure refinement for [Cu(oVATPNH2)2] (I) and [Zn(oVATPNH2)2] (II) 
 
 CuL2 ZnL2 
Empirical formula  C26H24N2O4S2Cu C26H24N2O4S2Zn 
Formula weight 556.13   557.96 
Temperature (K) 293(2)   294(2)    
Wavelength (Å) 0.71073   0.71073 
Crystal system Triclinic Monoclinic 
Space group 1P  C2/c 
Unit cell dimensions   
a(Å)  5.2558(3)  22.636(1) 
b(Å)  10.5965(5)   5.3423(3) 
c(Å)  11.1192(5)   20.8134(8) 
α(º)  99.818(4)   90.00 
β(º) 91.255(4)  104.814(4) 
γ(º) 102.935(4)   90.00 
Volume (Å3) 593.54(5)  2433.3(2) 
Z, density (calc., Mg/m3) 1, 1.556   4, 1.523 
Absorpt. coeff. (mm-1) 1.133   1.218 
F(000) 287  1152 
Crystal size (mm3) 0.307 x 0.184 x 0.020    0.256 x 0.097 x 0.033 
ϑ-range for data collect (º) 2.973 to 28.842  3.081 to 29.011 
Index ranges -6≤h≤7, -14≤k≤14, -14≤l≤14  -19≤h≤30, -7≤k≤4, -25≤l≤27 
Reflections collected 8440  5382 
Independentreflections 2685 [R(int) = 0.0369]  2652 [R(int) = 0.0285] 
Observed reflections [I>2σ(I)] 2267   2098 
Completeness (%) 99.9 (to ϑ = 25.242°)  99.8 (to ϑ = 25.242°) 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / parameters 2685 / 67 / 207 2652 / 49 / 206 
Goodness-of-fit on F2 1.080   1.073 
Final R indicesa [I>2σ(I)] R1 = 0.0357, wR2 = 0.0691  R1 = 0.0385, wR2 = 0.0780 
R indices (all data) R1 = 0.0469, wR2 = 0.0732  R1 = 0.0542, wR2 = 0.0845 
Larg. diff. peak &hole (e.Å-3) 0.264 and –0.316 e.Å-3   0.274 and -0.284 
aR1=Σ||Fo|-|Fc||/Σ|Fo|, wR2=[Σw(|Fo|2-|Fc|2)2/Σw(|Fo|2)2]1/2 
 
Regarding the structural study performed on solid oVaTPNH2,19 the relative orientation of the S atom in 
the heterocycle could be compatible with a tridentate behaviour of the ligand, as it has been observed 
in related compounds.20-23 However, in both complexes only N and O atoms are involved in 
coordination. Results of calculations in the gas phase and of those taking into account solvent effects 
(not shown) indicate that the more stable conformer has the thiophene ring rotated in approximately 90 
degrees from the benzene ring plane, a conformation that prevents the S atom from coordination. In 
Figure 2, shows the crystal packing of both complexes, it can be appreciated that the rotation angle of 
the thiophene ring is almost coincident with the one predicted in the gas phase. Thus, the lattice 
stabilization effect due to coordination to the metal is probably not strong enough to compensate for the 









Figure 2. Crystal packing of CuL2 (left) and ZnL (right)  
 
3.2. Optimized geometries and their comparison with experimental data Deleted section 
  
Geometrical parameters of both complexes were optimized using the computational procedure 
described in the experimental section 4.4 (see below). Geometrical parameters are listed in Table S6 
of the Supplementary Information where the results for CuL2 and ZnL2 are compared with the 
experimental crystallographic data. 
Optimized geometrical parameters for CuL2 show that the two ligands surrounding the metal ion are 
inequivalent, thus giving two values for each geometrical parameter. For bond distances and bond 
angles, the difference among the two calculated values for each inequivalent ligand is small, and 
therefore only average values are listed in Table S6. Nevertheless, as significant differences are 
observed in calculated dihedral angles of the two ligands, both values are included in the table. On the 
other hand, both ligands in complex ZnL2 are equivalent according to present calculations. 
It can be appreciated in Table S6 that bond distances around metal ions are well described by the 
computational methodology used in this work. Calculated N-M bond distance is overestimated by 0.024 
and 0.030 Å for CuL2 and ZnL2, respectively. For the O-M bond distance, calculated values also 
overestimated experimental data by 0.047 and 0.024 Å for CuL2 and ZnL2, respectively. Bond angles 
are very well described for Zn(II) complex with a maximum error of about 4 degrees. On the other 
hand, the bond angles with larger errors are those angles involved in the closest environment of Cu(II) 
ion. Errors are as large as 20 degrees for N-Cu-N’ and O1-Cu-O1’. 
Dihedral angles are also well described by the computational methodology used in the present work. 
Not surprisingly, the larger deviations from experimental data are observed in those angles involving 
the Cu(II) ion in the complex. C5’-N’-Cu-O1, C8-O1-Cu-N’, C8’-O1’-Cu-N and C6’-N’-Cu-O1 dihedral 
angles show errors in a range from 20 to almost 40 degrees. Although C1-C5-N-C6 and C1-C5-N-Zn 
angles depart from experimental values by about 40 degrees, the environment around the Zn(II) ion is 
well described. Interestingly, the S-C1-C5-N angles exhibit the largest deviation from experimental 
measurements in both complexes 
 
3.2. Vibrational Spectroscopy 
 
FTIR and Raman spectra of the complexes were registered and are presented in Figure S1 as 
Supplementary Information, they were analysed in comparison with the spectra of the free ligand we 
have previously reported. 19 Assignments were done based on reported data 43,44 and results on related 
species 13,45, and also assisted by DFT calculations. Changes in the frequency of the ligand vibrational 
modes were observed upon coordination to the metal. Moreover, new bands due to ligand-metal bonds 
appeared in the spectra of the complexes. The more relevant spectral region in the IR spectra of the 
ligand and the complexes is depicted in Figure 3. Selected relevant bands, assigned to modes 
involving coordinating atoms, are listed in Table 2 and a more complete list of spectroscopic 
information is available as supplementary information (table S6). As can be seen in the tables, 














Figure 3. IR spectra of the oVATPNH2 ligand (L) and the complexes CuL2 and ZnL2 
 
As predicted, upon deprotonation of the phenolic group, the bands related to the O-H vibrations of the 
free ligand are absent in the spectra of the complexes. The strong C=N stretching band at 1631 cm-1 
(IR) and 1635 cm-1 (Ra) in the ligand is shifted to lower wavenumbers in the complexes as the N atom 
participates in the coordination to the metal. As expected, weak bands assigned to the metal-ligand 
symmetric and anti-symmetric stretching are observed in the lower frequency region of the complexes’ 
spectra. In both cases, the O-M-O bands appear at higher wavenumbers than the N-M-N ones, as 
predicted by calculations and in accordance with the M-N distances longer than the M-O ones, also 
observed in related complexes involving N,O-donor ligands. The –N=C-C-C-O- moiety of each ligand 
bonded to the metal ion gives rise to a six-membered ring (coordination ring). In the complexes, 
vibrations of these rings are predicted at lower frequencies that the respective modes of the oVA ring. 
The ring stretching bands could not be detected, probably because they are overlapped with the 
intense bands near 1500 cm-1, due to the CH3 and CH2 bending modes. Nevertheless, weak bands 
related to de coordination ring deformations appeared at around 600 cm-1 (in-plane) and 400 cm-1 (out-
of-plane). 
Modes related to the o-Va and thiophene ring vibrations and those concerning the –CH2 and O-CH3 
groups show slight changes in frequency and/or intensity upon complex formation, as they are not 
directly affected by coordination. In particular for CuL2 two close, or even coincident, values are 
calculated for each mode of the ligand in the complex. This is due to the presence of two no strictly 
equivalent ligands in the coordination sphere of the metal centre.  
 
Table 2. Relevant bands in the vibrational spectra of CuL2 and ZnL2. Assignment and comparison with 
the free ligand data (wavenumbers in cm-1) 
 
oVATPNH2 (a) Cu(oVATPNH2)2  Zn(oVATPNH2)2 
IR. Raman Calc Assignment IR Raman  Calc. Assignment  IR Raman Calc Assignment 
3003 vw 3005 w 3153 ν O-H          
1631 vs 1635 
vs 
1685 ν C=N 1618 vs 1624 s 1665/1659 ν C=N  1615 vs 1628 s 1660/1651 ν C=N  
1583 sh 1587 m 1660 
1618 
ν ring (oVA)  












1640 νring (oVA) 
1415 m,b  1480 
1460 
δ CH2 
δ O-H + δs CH3 
+ δ C-H(oVA) 
1405 w 1404 sh 1489/1484 
1472 
δ CH2 
ν coord. ring +δ CH2 
+ δs CH3 
1407 m 1420 sh 1491/1474 
1465/1461 
δ CH2 + δs CH3   
ν coord. ring + δ CH2 
+ δs CH3 
1361 m 1365 w 1370 δ O-H + ν ring 
(oHVA) 




ν ring (oVA + 
Tph)+δs CH2 
δ C-H (Ar-CH) 
1353 w, b 1360 s 1393/1394 ν ring (oVA + 
Tph) + δ CH 
(ArCH) + ρw CH2 
832 ms,b 838 w 851 γ O-H         
    489 vw 
475 vw 471 w 
565 
559 
νas O-Cu-O  
νs O-Cu-O  
477 vvw  568 
563 
νas O-Zn-O  
νs O-Zn-O  





















γ coord. ring 
 
(a) Data extracted from ref 19. vs: very strong, s: strong, m: medium, w: weak, vw: very weak, b: broad, sh: shoulder: 





3.3. EPR Spectroscopy. 
 
X-band EPR spectra of powdered solid samples of CuL2 at different temperatures are given as ESI 
(Figure S2). No relevant variations are observed in the studied temperature range. Despite the shape 
of the signal resembles an axial symmetry feature, the best fit is obtained for a rhombic distortion (see 
Figure 4). The calculated g-values are g1 = 2.240, g2 = 2.065 and g3 = 2.043, where the value of g1 is 
calculated with some uncertainty due to the broadness and weakness of the absorption in the parallel 
component. All the spectra are characteristic of dx2-y2 ground-state, in good agreement with the square-








Figure 4. EPR spectrum of [Cu(oVATPNH2)2] (CuL2) at 150 K (solid line) together with the best fit 
(dashed line). Experimental details: modulation amplitude 0.1 mT, time constant 40.96 ms, conversion 
time 327.68 ms, gain 1 103 (short ranges) or 1 104 (long 0 ‒ 700 mT ranges) and power 20 mW. 
Microwave frequency 9.4260 GHz. 
Calculated G-value 46 is 4.44 (see Equation 1), which suggests negligible magnetic exchange 
interactions, as expected for the monomeric character of the paramagnetic centre, in agreement with 
the vibrational spectroscopic results and supporting the predicted structure. 
 
    Equation 1 
In order to have some information about the behaviour of the complex in solution, the X-band EPR 
spectra of a CuL2 5 10−4 M in (1:1) (DMSO:ethanol) are recorded. The room temperature spectrum is 
depicted in Figure S3 (ESI). Despite the low resolution, giso = 2.115 and Aiso = 82 G (81.0 10−4 cm−1) 
parameters can be deduced. The measurements carried out in frozen solution at 150 K are 
characteristic of a dx2-y2 ground-state (Figure S4), and the best fit yields the following values: g|| = 
2.224; A|| = 185 G (192.1 10−4 cm−1); and g⊥ = 2.055. The analogies of these g-values with those 
calculated in solid state suggest that the molecular structure is roughly retained in solution. Finally, the 
representation of A|| vs. g|| falls in the area predicted by Blumberg and Peisach Peisach, 47 for Cu(II) 











3.4. Electronic Spectroscopy 
 
Electronic spectra of the complexes are recorded in DMSO solution (approximately 10-3 M and 10-5 M) 
in the 250-800 nm spectral range and diffuse reflectance spectra of the solids are also measured (see 
Figure 5). 
Spectra in solution of the ligand and the complexes do not change during 48 hours, hence denoting 
their stability in the selected solvent. The absorption bands in solution were assigned with the 
assistance of theoretical calculations. Calculated electronic transitions are selected according to their 
oscillator strengths. Experimental and calculated spectra for each complex show a good accordance, 















Figure 5: Top: Experimental (solid) and calculated (dashed) electronic spectra of the complexes 
registered for 5x10-5 M DMSO solutions. Higher concentration (5x10-3 M) was employed to register d-d 
transitions in complexes CuL2. Bottom: Diffuse reflectance spectra of solid samples. 
 
Table 3 lists experimental bands and calculated electronic transitions for the complexes, along with 
their assignment. The positions of the maxima are determined by deconvolution of the experimental 
spectra in the poorly resolved regions. Maxima of the higher energy bands are approximate, due to the 
proximity of the solvent cut-off. Present calculations show that many-body effects are far from 
negligible as most of calculated transitions are described by several one-electron excitations, thus 
involving several MO’s. To simplify the description of transitions and the corresponding assignment of 
experimental bands, an arbitrary threshold to the one-electron excitation coefficients obtained from the 
TD-DFT is imposed. This way, the number of one-electron excitations selected to describe the 
experimental bands is considerably reduced. Graphical representations of the OM’s involved in the 
electronic transitions of CuL2 and ZnL2 (Figures S5 and S6, respectively) and their description are 
available as ESI. 
When compared with the electronic spectra ofoVATPNH2, a blue shift of the intra ligand bands (at 263 
and 331 nm in the free ligand) is observed in both complexes, as a consequence of coordination. 
Furthermore, charge transfer bands appear in the spectra in the expected wavelengths. It is interesting 
to mention that, d-d bands in the Cu(II) complex observed at 693 and 617 nm in solution and at 692 
and 587 nm in the solid state are in accordance with a planar square environment of the d9 copper ion. 
Even though three bands are predicted for this symmetry, the one at higher energy is frequently hidden 
under the stronger charge transfer band. 48,49 In this case, deconvolution of the broad band at 381 nm 
shows the best fit considering two maxima, in accordance with the calculated transition. 
The shifts in the band positions and the differences in intensity between the diffuse reflectance spectra 
obtained from the solid sample and the absorbance spectra in solution of each compound are a 
consequence of the different physical basis of both measurement method, the way in that data is 
analyzed and the expected solvent effect. 50 The results indicate that there are no significant changes 
in the metal environment when compared solid samples with solutions. 
Transitions at higher energy are predicted by calculations but they are expected at a lower wavelength 
than the solvent cut-off. It is worth noting that many experimental bands are described by more than 
one single electronic calculated transition. 
  
Table 3. Experimental and calculated electronic spectra of the complexes in DMSO solution. Band 
maxima and transition energies are given in nm. Molar absorptivity (in M-1.cm-1) and calculated 
oscillator strength (in atomic units) are in parentheses. The proposed assignment is also given. H and 
L are used as short notation for HOMO and LUMO, respectively, whereas α and β refer to the 
electronic spin channels, when needed. 
 
Experimental	   Calculated	   Transition	   Assignment	  
CuL2	  
693 (51)	   735 (0.0007)	   Hβ → Lβ	   d → d  
617 (18)	   532 (0.0034)	   Hβ – 10 → Lβ	   d → d 
558 (35)* 435 (0.0193) Hβ → Lβ 
d → d  
Ligand-to-metal charge transfer 
381 (3.2 x103) 370 (0.0588)	  
Hα → Lα +1	  
Hβ → Lβ +2	  
Intra- and interligand	  
289 (sh) 	  
303 (0.0634)	   Hβ – 3 → Lβ +2	   Intraligand	  
302 (0.0623)	   Hβ – 8 → Lβ	   Ligand-to-metal charge transfer	  
276 (1.6 x104)	   262 (0.1605)	  
Hα – 6 → Lα	  
Hα – 5 → Lα	  
Hβ – 4 → Lβ + 2	  
Intra- and interligand	  
258 (**)	   228 (0.1933)	   Hα – 4 → Lα +2	   Intra- and interligand	  
ZnL2	  
383 (4.6 x103)	   363.6 (0.0517)	   H → L	   Intra- and interligand	  
283 (9.3 x103) 
290.1 (0.1505) H – 2 → L Intra- and interligand 
273.0 (0.0907)	   H – 8 → L	   Intra- and interligand	  
Metal-to-ligand charge transfer	  
259 (**)	   258.7 (0.3105)	   H – 5 → L	   Intra- and interligand	  
 
(*) The transition calculated at 435 nm in complex CuL2 presents two monoelectronic components from 
the HOMOβ – 13 and the HOMOβ – 23 to the LUMOβ, which are responsible for the lower wavelength of 
this transition with respect to the one calculated at 735 nm. The band found at 558 nm by deconvolution 
is hidden under the strong absorption with maximum at 381 nm. 
(**) Undefined maxima due to solvent cut-off. 
 
3.5. NMR Spectroscopy 
 
In order to complete the characterization of the ZnL2 complex in solution, 1H and 13C NMR spectral in 
(CD3)2SO were recorded and compared with those obtained for the free ligand.19 Table 4 shows the 
positions and assignments of the signals. As expected, the deprotonation of the OH group in the ligand 
is evident in the complex. The results are consistent with the proposed coordination feature, as the 
atoms near the donor set are those with larger variations in the chemical shifts. Figures of the spectra 
and 2D registers are included in ESI (Figures S7-S10) 
 
Table 4. 1H and 13C NMR of complex ZnL2 in (CD3)2SO solution. Data for the HL ligand is included for 
comparison. Chemical shifts δ (ppm), J (Hz) and assignments. 
 
 1H NMR 13C NMR 
C/H ZnL2 HL ZnL2 HL 
C6	   8.44	  (s,	  1H)	   8.68	  (s)	   171.51	   166.78	  
C8	   -­‐	   13.35	  (s)	   161.81	   150.83	  
C9	   -­‐	   -­‐	   152.02	   147.90	  
C1	   -­‐	   -­‐	   139.13	   141.31	  
C3	   7.33	  (d,	  J	  =	  5.1	  Hz,	  1H)	   7.03	  (dd,J=	  5.0,	  3.5	  Hz)	   127.62	   127.13	  
C4	   6.92	  –	  6.72	  (m,	  4H)	   7.47	  (dd,J=	  5.0,	  1.1	  Hz)	   127.38	   125.48	  
C2	   6.92	  –	  6.72	  (m,	  4H)	   7.06	  (m)	   127.03	   125.45	  
C12	   6.92	  –	  6.72	  (m,	  4H)	   7.06	  (m)	   126.47	   123.22	  
C7	   -­‐	   -­‐	   117.59	   118.43	  
C11	   6.45	  (t,	  J	  =	  7.8	  Hz,	  1H)	   6.84	  (dd,J	  =	  8.3,	  7.5	  Hz)	   115.34	   118.18	  
C10	   6.92	  –	  6.72	  (m,	  4H)	   7.06	  (m)	   112.55	   114.99	  
C5	   4.63	  (s,	  2H)	   4.99	  (s)	   56.64	   56.26	  
C13	   3.65	  (s,	  3H)	   3.78	  (s)	   55.65	   55.74	  
S:singlet, d: doublet, m: multiplet  
 
3.6. Thermal analysis 
 
The thermal behaviors of the ligand and the complexes were studied analyzing the TG and DT data 
obtained through the incineration of solid in oxygen flux (see Figure S11 in ESI). 
In the TG and DT curves of the ligand, the melting point is observed at 70.5°C. At 165°C starts the 
decomposition involving several exothermic processes, losing the 59% of mass in a first step, 
consistent with the removal of the substituted benzene ring fragment. This is followed by the loss of the 
remaining ligand´s fragments, leading to a total weight loss of 97%. 
For the CuL2 the melting point is observed at 227°C followed by its decomposition which takes place in 
several steps. The first one, corresponding to a weight loss of 27.0% at 213°C, is consistent with the 
loss of the (oVA + C=N) fragment (calculated weight loss of 26.8%). The second weight loss (58.0%) 
occurs with several exothermic processes from 277°C to 717°C, and corresponds to the removal of the 
remaining ligand, obtaining CuO as residue (corroborated by FTIR spectroscopy, 593, 527 cm-1). 
The analysis of the curves of ZnL2 shows the melting point at 195°C and a decomposition beginning at 
239°C with a first loss of 31.0% and a second one of 52.9% at 403°C, consistent with the loss of both 
ligands. The residue of 15.1% corresponds to ZnO (calculated 14.6%; IR: 482, 448 cm-1). 
Due to the thermal inertia during the heating process in the TG experiment, the recorded melting point 
values of the complexes have some differences with those determined in a Bockmonoscop “M” 
instrument. 
 
3.7. Cytotoxicity Assays. Evaluation of metal dependent activity on cell viability in breast cancer cell 
lines (MCF7 and MDA-MB-231). 
 
To test the effect of metal dependent cytotoxicity on cell viability two different breast cancer cell lines: 
MCF7 (breast adenocarcinoma) and MDA-MB-231 (triple negative breast adenocarcinoma) were 
assayed. These tumor cells were exposed to the ligand, the metal cation and the complex during 48 h. 
The anticancer activity of both complexes was investigated and compared with that of the free ligand 
(oVATPNH2) and respectively with CuII), Zn(II)) ions. 
Table 5 shows the IC50 values of the complexes and data for the reference metallodrug cisplatin 
(CDDP) are included for comparison. As it can be seen, both complexes impaired cell viability on 
MCF7 and MDA-MB-231 cells in the range of concentration (10-50 µM). The table also indicates that 
CuL2 is a stronger antiproliferative agent than ZnL2 and has an even stronger anticancer activity than 
CDDP in both tested breast cell lines. On the other hand, the IC50 values of the free ligand and free 
metal cations are greater than 100 µM for both cell lines tested, hence revealing the important role of 
complexation to modulate the antitumor properties of this kind of compounds. 
 
Table 5. IC50 (µM) values of complexes and CDDP on MCF7 and MDA-MB-231 after 48 h of 
incubation. Values for free ligand and metal ions are included for comparison. 
 
Cell line L CuL2 ZnL2 CDDP Cu(II) Zn(II) 
MCF7 > 100 13.9 ± 3.3 43.6 ± 0.16 19.3 ± 2.1 > 100 > 100 
MDA-MB-231 > 100 23.0 ± 1.52 41.7 ± 2.88 27.5 ± 2.14 > 100 > 100 
 
This positive effect has been described for other complexes of these metals and others such as 
platinum and palladium that have shown cytotoxic activity. 51,52  Particularly, copper have been more 
effective against both breast cancer cell lines (MCF7 and MDA-MB-231) than zinc. Comparison of IC50 
values with other copper complexes reveals that this complex can be included in the active group, as a 
potential cytotoxic agent. 53 In this sense, copper(II) complex of 4'methoxy-5,7-dihydroxy-isoflavone 
showed moderate cytotoxic effectiveness against human breast cancer cells with IC50 values in the 20-
50 µM range. 54 It is also important to highlight that even though  copper(II) complexes with 
mononegative bidentate S,N-Schiff bases derived from S-benzyl- and S-methyl dithiocarbazate 
showed selective activity against MCF-7 cells (IC50= 0.45 µM), they were inactive against MDA- MB-
231 cells. 55 The same cell specificity was observed for copper complexes with Schiff bases benzyl N-
[1-(thiophen-2-yl)ethylidene] hydrazine carbodithioate and benzyl N-[1-(thio- phen-3-yl)ethylidene].56 
The effectiveness of copper complex could be associated with its planar conformation, but further 
mechanistic studies are required to determine the correlation. Results have been reported on some 
copper complexes more effective than platinum compounds as antitumor agents on prostate and 
breast and cancer cells. 57 Considering that generally copper compounds have less toxic side effects 





The interaction of oVATPNH2 with Cu(II) and Zn(II) lead to the formation of stable complexes, namely 
[Cu(oVATPNH2)2] (CuL2) and [Zn(oVATPNH2)2] (ZnL2). Despite the presence of the S, N and O donor 
atoms in the ligand, it acts as a bidentate ligand through the phenoxo oxygen and the imine nitrogen 
atoms in both complexes. 
The crystal structures of the complexes reveal a nearly square planar environment for the copper 
centre and a tetrahedral coordination sphere in the case of Zn cation. In both cases the thiophene ring 
appears almost perpendicular to the coordination plane in the ligand, increasing the deviation from the 
benzenic ring as compared with the free ligand. 
Spectroscopic behaviour completely accords with the structural properties of the complexes and 
reveals that the coordination sphere is retained in solution. Calculated parameters and frequencies 
assisted the interpretation of the experimental results and show good agreement. The vibrational 
modes of the free ligand are consequently changed upon its deprotonation followed by coordination to 
the metal and new bands related to metal-ligand bonds are observed. For CuL2, the EPR spectra are 
characteristic of a dx2-y2 ground-states and the expected d-d transitions can be identified in the 
electronic spectra, according to the distorted square-planar environment of the Cu(II) centre. 
Cytotoxicity studies on two breast cancer cell lines show the beneficial effect of metal complexation on 
the antitumoral action compared with either the free ligand or the metal ions independently. The copper 
complex is more active against both lines, with IC50 values lower than those of CDDP. Considering the 
lower toxicity of copper with platinum and the limitations in the treatment of triple-negative breast 
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spectra along with the assignment (Table S6), FTIR and Raman spectra in the whole spectral range 
(Figure S1); EPR spectra of CuL2 solid sample (Figures S2) and in solution (Figures S3 and S4) at 
different temperatures, MOs involved in relevant electronic transitions of the complexes (Figures S5 
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